News

You’re Unlikely To Get Alphabet Stock Cheaper Than This (NASDAQ:GOOG)

1 Mins read

This article was written by

Oakoff Investments is a personal portfolio manager and a quantitative research analyst with 5 years helping readers find a reasonable balance between growth and value by sharing proprietary Wall Street information.

He leads the investing group Beyond the Wall Investing with features that include: a fundamentals-based portfolio, weekly analysis on insights from institutional investors, regular alerts for short-term trade ideas based on technical signals, ticker feedback by request from readers, and community chat. Learn more.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of GOOG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Viper Energy: A High-Margin Royalty Machine With 10% Yield Potential (NASDAQ:VNOM)

1 Mins read
This article was written by Follow English and Brazilian Portuguese translator, proofreader, editor, and content writer specializing in Finance, Economics, and Investments….
News

Capital Markets Remain Unsettled With Oil Above $100

1 Mins read
Marc Chandler has been covering the global capital markets in one fashion or another for 25 years, working at economic consulting firms…
News

Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP)

2 Mins read
This article was written by Follow I hold a Master’s degree in Cell Biology and began my career working for several years…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *